Clinical Trial Update: Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a carfilzomib/SAHA combination with high-dose gemcitabine/busulfan/melphalan and autologous stem cell transplant for multiple myeloma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Carfilzomib (carfilzomib)
• Gemcitabine (Gemcitabine)
• Melphalan (Melphalan)
• SAHA (vorinostat) (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | Phase 2 | Status: WITHDRAWN